GLG V 78
Alternative Names: GLG IV 78Latest Information Update: 30 May 2001
At a glance
- Originator Nonindustrial source
- Class Antiarrhythmics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 14 Apr 1997 No-Development-Reported for Arrhythmias in USA (Unknown route)
- 17 May 1995 Preclinical development for Arrhythmias in USA (Unknown route)